Randomized trial demonstrates that intrauterine oxytetracycline at 12 hours post-insemination reduces embryonic loss in dairy cows, suggesting timing-dependent fertility benefits.
The aim of this study was to evaluate the effects of povidone-iodine and oxytetracycline, administered intrauterinely at different time points following artificial insemination, on pregnancy rates and embryonic losses in dairy cows. The study was conducted on a total of 350 clinically healthy Holstein cows, synchronized using the Ovsynch protocol, between 50 and 60 days postpartum. The animals were randomly assigned to a control group and six experimental groups that received povidone-iodine (PI) or oxytetracycline (OTC) 4, 12, and 24 h after artificial insemination. Pregnancy rates and embryonic loss rates following the first insemination were determined via ultrasonographic examinations conducted between 1 and 4 months after insemination. According to the results, while no statistically significant difference was found in pregnancy rates, the lowest embryonic loss rate (6.7%) was observed in the group treated with oxytetracycline 12 h after artificial insemination. In contrast, the highest embryonic loss rate (27.8%) was observed in the control group. Overall, it was determined that the groups treated with oxytetracycline demonstrated better fertility outcomes compared to the groups treated with povidone-iodine across all time periods. In conclusion, it was concluded that intrauterine oxytetracycline administered after artificial insemination, particularly at the 12-hour mark, reduces embryonic losses; therefore, intrauterine antibiotic administration at the appropriate time may be an effective approach for improving fertility in dairy cows.
No takes yet. Share an insight, caveat, or question.
Sobirov et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: